Authors: SLAUGHTER RL CAPPELLETTY DM

Citation: Rl. Slaughter et Dm. Cappelletty, ECONOMIC-IMPACT OF AMINOGLYCOSIDE TOXICITY AND ITS PREVENTION THROUGHTHERAPEUTIC DRUG-MONITORING, PharmacoEconomics, 14(4), 1998, pp. 385-394

Authors: RYBAK MJ CAPPELLETTY DM MOLDOVAN T AESCHLIMANN JR KAATZ GW

Citation: Mj. Rybak et al., COMPARATIVE IN-VITRO ACTIVITIES AND POSTANTIBIOTIC EFFECTS OF THE OXAZOLIDINONE COMPOUNDS EPEREZOLID (PNU-100592) AND LINEZOLID (PNU-100766) VERSUS VANCOMYCIN AGAINST STAPHYLOCOCCUS-AUREUS, COAGULASE-NEGATIVE STAPHYLOCOCCI, ENTEROCOCCUS-FAECALIS, AND ENTEROCOCCUS-FAECIUM, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 721-724

Authors: CAPPELLETTY DM RYBAK MJ

Citation: Dm. Cappelletty et Mj. Rybak, BACTERICIDAL ACTIVITIES OF CEFPROZIL, PENICILLIN, CEFACLOR, CEFIXIME,AND LORACARBEF AGAINST PENICILLIN-SUSCEPTIBLE AND PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE IN AN IN-VITRO PHARMACODYNAMIC INFECTION MODEL, Antimicrobial agents and chemotherapy, 40(5), 1996, pp. 1148-1152

Authors: CAPPELLETTY DM RYBAK MJ

Citation: Dm. Cappelletty et Mj. Rybak, COMPARISON OF METHODOLOGIES FOR SYNERGISM TESTING OF DRUG-COMBINATIONS AGAINST RESISTANT STRAINS OF PSEUDOMONAS-AERUGINOSA, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 677-683

Authors: BENKO AS CAPPELLETTY DM KRUSE JA RYBAK MJ

Citation: As. Benko et al., CONTINUOUS-INFUSION VERSUS INTERMITTENT ADMINISTRATION OF CEFTAZIDIMEIN CRITICALLY ILL PATIENTS WITH SUSPECTED GRAM-NEGATIVE INFECTIONS, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 691-695

Authors: CAPPELLETTY DM KANG SL PALMER SM RYBAK MJ

Citation: Dm. Cappelletty et al., PHARMACODYNAMICS OF CEFTAZIDIME ADMINISTERED AS CONTINUOUS-INFUSION OR INTERMITTENT BOLUS ALONE AND IN COMBINATION WITH SINGLE DAILY-DOSE AMIKACIN AGAINST PSEUDOMONAS-AERUGINOSA IN AN IN-VITRO INFECTION MODEL, Antimicrobial agents and chemotherapy, 39(8), 1995, pp. 1797-1801